Background& Objectives: Obesity which is an alarming medical disorder usually presented with inflammation of low grade is documented to be associated with elevated level of C-reactive protein (CRP), a renowned protein of acute phase produced by the liver. We conducted this study to correlate the likely inflammatory role in obese diabetic and non diabetics. Methods: We measured serum glucose in fasting state of 6-8 hours; serum insulin and levels of CRP in forty obese diabetics with BMI of 35 ± 5 kg/m2 and forty non diabetics obese with BMI of 33 ± 3 kg/m2. Model of HOMA IR was used to assess insulin resistance. Data was presented as mean with standard deviation of every parameter of the current study. P value less than 0.05 was reflected ...
Objective: T2DM (Type 2 Diabetes Mellitus) and IR (Insulin Resistance) have an association with each...
Objective: In this study, the main objective was to evaluate the association of markers of obesity w...
ABSTRACT BACKGROUND: The glucagon-like peptides 1 and 2 (GLP-1/GLP-2) are gut hormones that may di...
Background & Objectives:- Protein made by the liver C-reactive protein (CRP) is a well known indica...
Background & Objectives:- Protein made by the liver C-reactive protein (CRP) is a well known indica...
Background & Objectives:- Protein made by the liver C-reactive protein (CRP) is a well known indica...
OBJECTIVES: A growing body of evidence emerges that obesity, metabolic syndrome, type 2 diabetes and...
Objectives: We sought to determine the role of obesity and insulin resistance (IR) in the pathogenes...
R ecent studies have shown that low-grade inflammation is linked bothto insulin resistance (1,2) and...
Protein made by the liver C-reactive protein [CRP] is a well known indicator of systemic inflammatio...
OBJECTIVE: The associations between inflammation, diabetes and insulin resistance remain controversi...
Background: Chronic inflammation is related to both obesity and diabetes. Our aim was to investigate...
Background: Chronic inflammation is related to both obesity and diabetes. Our aim was to investigate...
Background: Chronic inflammation is related to both obesity and diabetes. Our aim was to investigate...
BACKGROUND/OBJECTIVES: To assess the distribution of interleukin (IL)-1β, IL-6, tumour necrosis fact...
Objective: T2DM (Type 2 Diabetes Mellitus) and IR (Insulin Resistance) have an association with each...
Objective: In this study, the main objective was to evaluate the association of markers of obesity w...
ABSTRACT BACKGROUND: The glucagon-like peptides 1 and 2 (GLP-1/GLP-2) are gut hormones that may di...
Background & Objectives:- Protein made by the liver C-reactive protein (CRP) is a well known indica...
Background & Objectives:- Protein made by the liver C-reactive protein (CRP) is a well known indica...
Background & Objectives:- Protein made by the liver C-reactive protein (CRP) is a well known indica...
OBJECTIVES: A growing body of evidence emerges that obesity, metabolic syndrome, type 2 diabetes and...
Objectives: We sought to determine the role of obesity and insulin resistance (IR) in the pathogenes...
R ecent studies have shown that low-grade inflammation is linked bothto insulin resistance (1,2) and...
Protein made by the liver C-reactive protein [CRP] is a well known indicator of systemic inflammatio...
OBJECTIVE: The associations between inflammation, diabetes and insulin resistance remain controversi...
Background: Chronic inflammation is related to both obesity and diabetes. Our aim was to investigate...
Background: Chronic inflammation is related to both obesity and diabetes. Our aim was to investigate...
Background: Chronic inflammation is related to both obesity and diabetes. Our aim was to investigate...
BACKGROUND/OBJECTIVES: To assess the distribution of interleukin (IL)-1β, IL-6, tumour necrosis fact...
Objective: T2DM (Type 2 Diabetes Mellitus) and IR (Insulin Resistance) have an association with each...
Objective: In this study, the main objective was to evaluate the association of markers of obesity w...
ABSTRACT BACKGROUND: The glucagon-like peptides 1 and 2 (GLP-1/GLP-2) are gut hormones that may di...